T-Cell Therapy Firm Wins Massive €93M Series A to Treat Solid Tumors
The Dutch startup Neogene Therapeutics has become the second T-cell therapy developer to raise a…
The Dutch startup Neogene Therapeutics has become the second T-cell therapy developer to raise a…
Genetic engineering is breaking new ground in the control of mosquito-borne diseases. However, a genetic…
In recent times, an unexpectedly large number of investments have closed in biotech startups offering…
After years of drought, recent technological and clinical breakthroughs are causing research into chronic kidney…
Providers of microbiome therapies worldwide have been hit by pandemic restrictions on the harvest of…
The first generation of vaccines for Covid-19 is edging closer to the market. But are…
A drug developed by the US firm Unity Biotechnology -- designed to slow the aging…
Despite the recent EU approval of the first hepatitis D treatment, low public awareness remains…
Bayer’s recent €736M ($875M) acquisition of KaNDy Therapeutics could herald growing investor interest in women’s…
The share price of CureVac has skyrocketed almost fivefold after the Covid-19 vaccine developer priced…
European companies developing advanced therapies such as gene and cell therapies secured at least €2.2B…
European biotech companies are flocking to the Nasdaq Stock Market in 2020, but not all…